Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism have mild symptoms and often experience acne, menstrual irregularities, and obesity.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Diagnose and treat hirsutism with oral contraceptives and laser hair removal for best results.

Most women with excessive hair growth in South India have hirsutism without a known cause, with common facial hair growth and some showing hormonal imbalances and polycystic ovaries.

Laser treatment can effectively reduce unwanted hair growth, particularly for people with fair skin and dark hair.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Finasteride and metformin both help treat PCOS, but using them together works best.

PCOS often causes acne, dark skin patches, excess hair, and hair loss, linked to hormone levels and obesity.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

PCOS is likely inherited in families, increasing risk for first-degree relatives.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Spironolactone plus finasteride reduces hirsutism more effectively.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.